Skip to main content

Advertisement

Fig. 6 | BMC Medicine

Fig. 6

From: A randomised, double-blind clinical phase II trial of the efficacy, safety, tolerability and pharmacokinetics of a single dose combination treatment with artefenomel and piperaquine in adults and children with uncomplicated Plasmodium falciparum malaria

Fig. 6

Estimated Cday7 for artefenomel (a) and PQP (b) by region/age group. Patients who vomited are included. Median (horizontal line), box (interquartile range) and whiskers represent the most extreme individual point which is not more than 1.5× the length of the box

Back to article page